Key Takeaways

• Topcon Healthcare increased its research presence at the 2026 ARVO meeting, with 80 accepted abstracts and 11 presentations.
• The company emphasized the growing role of retinal imaging, AI, oculomics, and connected care in both ophthalmology and broader healthcare.
• Topcon supported collaboration and education around AI-enabled healthcare through its symposium, “AI as the Bridge to Connected Care,” and by co-sponsoring the spring meeting of the Alliance for Healthcare from the Eye.

Topcon Healthcare announced a significant expansion of its scientific presence at the Association for Research in Vision and Ophthalmology (ARVO) 2026 conference, underscoring the role of ocular imaging, AI, oculomics, and connected care technologies in advancing ophthalmic research and broader health care innovation.

Topcon presentations have nearly tripled over the past 4 years, culminating this year with 80 accepted abstracts and 11 presentations across ARVO and the Imaging in the Eye scientific event. Topcon-related research was also presented among three ARVO Hot Topics recognitions, selected for their relevance to emerging areas shaping the future of medicine and vision research leveraging AI-based approaches.

“This continued growth reflects the increasing importance of advanced retinal imaging, AI, and connected care in driving scientific discovery,” said Daniela Ferrara, MD, PhD, Topcon Healthcare’s chief medical officer. “We are proud to empower researchers and clinicians with innovative technologies that enable deeper clinical insights, more data-driven decision-making, and new opportunities for earlier detection of vision-threatening and systemic diseases. The inspiring momentum at ARVO also reinforces the growing recognition that the eye can serve as a powerful, noninvasive window into overall health and healthy aging through the science of oculomics.”

As part of its ARVO 2026 activities, Topcon Healthcare hosted an educational symposium, “AI as the Bridge to Connected Care,” which explored the role of AI and advanced retinal imaging in identifying biomarkers for retinal, cardiovascular, metabolic, and neurodegenerative diseases. The program also highlighted the potential of AI-enabled endpoints, real-world data, and connected care models to transform clinical research and patient care.

Featured speakers included experts across clinical care, drug development, retinal imaging, AI, or digital health, including Daniela Ferrara, Michael Abramoff, Hasenin Al-khersan, Manjot Gill, Pearse Keane, David Rhew, and Ali Tafreshi.

Topcon Healthcare also co-sponsored the spring meeting of the Alliance for Healthcare from the Eye (AHE), a collaborative forum focused on advancing the responsible use of data, AI, and connected care models to improve disease detection, patient access, and health outcomes. The meeting brought together stakeholders committed to Healthcare from the Eye by exploring how insights from ocular data can contribute to the future of preventive, personalized, data-driven management of serious systemic and ocular diseases.

Together, Topcon Healthcare’s scientific presence at ARVO 2026, the “AI as the Bridge to Connected Care” symposium, and the Alliance for Healthcare from the Eye meeting reflect a broader shift in medicine, which is the growing recognition that the eye can provide critical insights into both ocular and systemic health.